Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results

por Mansukhani, Raoul, Frimley, Lauren, Shakur-Still, Haleema, Sharples, Linda, Roberts, Ian
Publicado 2020

Trial management: we need a cadre of high-class triallists to deliver the answers that patients need

por Beaumont, Danielle, Arribas, Monica, Frimley, Lauren, Balogun, Eni, Roberts, Ian, Shakur-Still, Haleema
Publicado 2019

Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial

por Brenner, Amy, Belli, Antonio, Chaudhri, Rizwana, Coats, Timothy, Frimley, Lauren, Jamaluddin, Sabariah Faizah, Jooma, Rashid, Mansukhani, Raoul, Sandercock, Peter, Shakur-Still, Haleema, Shokunbi, Temitayo, Roberts, Ian
Publicado 2020